These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9123122)

  • 21. Absorption of cyclosporine (Neoral) from a microemulsion formulation in a living donor liver transplant recipient.
    Maeda Y; Kuzuya T; Ota S; Yamada K; Kobayashi T; Hayashi S; Yokoyama I; Nakao A; Nabeshima T
    Transplant Proc; 2002 Nov; 34(7):2784-7. PubMed ID: 12431611
    [No Abstract]   [Full Text] [Related]  

  • 22. Microemulsion technology in the reformulation of cyclosporine: the reason behind the pharmacokinetic properties of Neoral.
    Ritschel WA
    Clin Transplant; 1996 Aug; 10(4):364-73. PubMed ID: 8884110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine pharmacology.
    Lee JI; Canafax DM
    Transplant Proc; 1996 Aug; 28(4):2156-8. PubMed ID: 8769185
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of bile on cyclosporin absorption from microemulsion formulation in primary liver transplant recipients.
    Winkler M; Ringe B; Oldhafer K; Kattner A; Färber L; Maibücher A; Wonigeit K; Pichlmayr R
    Transpl Int; 1995; 8(4):324-6. PubMed ID: 7546157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of microemulsion form cyclosporine immediately after kidney transplantation without intravenous cyclosporine.
    Jirasiritham S; Sumethkul V; Mavichak V; Jirasiritham S
    Transplant Proc; 1998 Aug; 30(5):1760-1. PubMed ID: 9723270
    [No Abstract]   [Full Text] [Related]  

  • 26. Improving the oral absorption of cyclosporine in malabsorbers: a review of the Neoral Compassionate Need Program.
    Mueller EA; Kovarik JM; Pittrow D
    Transplant Proc; 1998 Aug; 30(5):1691-3. PubMed ID: 9723246
    [No Abstract]   [Full Text] [Related]  

  • 27. Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients.
    Dunn SP; Cooney GF; Kulinsky A; Falkenstein K; Pierson A; Elder CA; Meligeni J
    Transplantation; 1995 Dec; 60(12):1438-42. PubMed ID: 8545871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of cyclosporine pharmacokinetics to clinical outcomes after liver transplantation. Canadian Liver Transplant Study Group.
    Transplant Proc; 1998 Aug; 30(5):1826-7. PubMed ID: 9723297
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics of an oral solution of the microemulsion formulation of cyclosporine in maintenance pediatric liver transplant recipients.
    Dunn S; Cooney G; Sommerauer J; Lindsay C; McDiarmid S; Wong RL; Chang CT; Smith HT; Choc MG
    Transplantation; 1997 Jun; 63(12):1762-7. PubMed ID: 9210501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group.
    Grant D; Rochon J; Levy G
    Transplant Proc; 1996 Aug; 28(4):2232-3. PubMed ID: 8769208
    [No Abstract]   [Full Text] [Related]  

  • 31. Cyclosporine conversion from conventional to microemulsion formulation: effect on renal concentration ability in stable hepatic transplant recipients.
    Fernandez-Fresnedo G; Escallada R; Casafont F; Fábrega E; de Cos MA; Rodrigo E; Cobo M; Cotorruelo JG; Pons F; Arias M
    Transplant Proc; 1997; 29(1-2):547-8. PubMed ID: 9123123
    [No Abstract]   [Full Text] [Related]  

  • 32. Benefits of cyclosporine microemulsion (Neoral) C(2) monitoring are sustained at 1 year in de novo liver transplant recipients.
    Lake JR;
    Transplant Proc; 2001; 33(7-8):3092-3. PubMed ID: 11750328
    [No Abstract]   [Full Text] [Related]  

  • 33. Microemulsion formulation increases cyclosporin bioavailability in cystic fibrosis.
    Mikhail GW; Eadon H; Rogers P; Leaver N; Banner NR; Khaghani A; Yacoub MH
    Lancet; 1995 Dec; 346(8990):1638-9. PubMed ID: 7500788
    [No Abstract]   [Full Text] [Related]  

  • 34. Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a Neoral-equivalent cyclosporine formulation, using a dose-adjusted method.
    First MR; Weiskittel P; Shah M; Peddi VR; Canafax D; Schroeder TJ
    Transplant Proc; 1998 Dec; 30(8):3955-7. PubMed ID: 9865260
    [No Abstract]   [Full Text] [Related]  

  • 35. Neoral without intravenous cyclosporine in liver transplantation.
    Hemming AW; Greig PD; Cattral MS; Chung SW; Lilly LB; Aljumah AA; Levy GA
    Transplant Proc; 1997; 29(1-2):543. PubMed ID: 9123121
    [No Abstract]   [Full Text] [Related]  

  • 36. Interim analysis of study OLN-356: Neoral versus Sandimmune in US primary liver transplant recipients. OLN-356 Principal Investigators.
    Pinson CW; Beauregard-Zollinger L
    Transplant Proc; 1996 Aug; 28(4):2234-6. PubMed ID: 8769209
    [No Abstract]   [Full Text] [Related]  

  • 37. Conversion to cyclosporine microemulsion (Neoral) in stable renal transplant patients: results from a single center.
    Cossu M; Satta R; Branca GF; Pala PG; Serra G; Satta RP; Sorba G
    Transplant Proc; 1998 Aug; 30(5):1762-3. PubMed ID: 9723271
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetic studies of oral and intravenous cyclosporine in prekidney transplant patient.
    Wacke R; Bast R; Rohde B; Prall F; Seiter H; Drewelow B
    Transplant Proc; 1998 Aug; 30(5):1663. PubMed ID: 9723233
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.
    Dunn CJ; Wagstaff AJ; Perry CM; Plosker GL; Goa KL
    Drugs; 2001; 61(13):1957-2016. PubMed ID: 11708766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absorption of cyclosporine Neoral early after liver transplantation: influence of bile on oral absorption.
    Oldhafer K; Haller GW; Kattner A; Winkler M; Maibücher A; Färber L; Bechstein WO; Ringe B; Neuhaus P; Pichlmayr R
    Transplant Proc; 1996 Aug; 28(4):2237-8. PubMed ID: 8769210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.